Comments
Loading...

Allogene Therapeutics Earnings Estimates

ALLONASDAQ
Logo brought to you by Benzinga Data
$1.69
0.010.60%
Pre-Market: 8:17 AM EDT

Allogene Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ALLO | Benzinga

Allogene Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 12
EPS Estimate
$-0.220
Quarterly Revenue Estimate
$4.17K
Annual Revenue
(as of Dec 31)
$22.00K

Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.

Get Alert
ALLOAllogene Therapeutics-$0.38-$0.22$22.00K$4.17K05/12/2025Get Alert
ALLOAllogene Therapeutics-$0.51-$0.34-$0.2817.65%$21.00K$14.00K$0.00-100.00%03/13/2025Get Alert
ALLOAllogene Therapeutics-$0.37-$0.33-$0.323.03%$43.00K$10.00K$0.00-100.00%11/07/2024Get Alert
ALLOAllogene Therapeutics-$0.53-$0.35-$0.350.00%$44.00K$20.00K$0.00-100.00%08/07/2024Get Alert
ALLOAllogene Therapeutics-$0.68-$0.41-$0.387.32%$30.00K$10.00K$22.00K120.00%05/13/2024Get Alert
ALLOAllogene Therapeutics-$0.67-$0.45-$0.434.44%$26.00K$20.00K$21.00K5.00%03/14/2024Get Alert
ALLOAllogene Therapeutics-$0.58-$0.52-$0.3728.85%$49.00K$10.00K$43.00K330.00%11/02/2023Get Alert
ALLOAllogene Therapeutics-$0.52-$0.59-$0.5310.17%$86.00K$70.00K$44.00K-37.14%08/02/2023Get Alert
ALLOAllogene Therapeutics-$0.56-$0.62-$0.68-9.68%$61.00K$10.00K$52.00K420.00%05/03/2023Get Alert
ALLOAllogene Therapeutics-$0.54-$0.70-$0.665.71%$51.00K$60.00K$47.00K-21.67%02/28/2023Get Alert
ALLOAllogene Therapeutics-$0.57-$0.64-$0.589.38%$49.00K$10.00K$49.00K390.00%11/02/2022Get Alert
ALLOAllogene Therapeutics-$0.53-$0.61-$0.5214.75%$44.00K$10.00K$86.00K760.00%08/09/2022Get Alert
ALLOAllogene Therapeutics-$0.25-$0.58-$0.563.45%$38.34M$61.00K05/04/2022Get Alert
ALLOAllogene Therapeutics-$0.53-$0.60-$0.5410.00%$0.00-$10.00K$51.00K610.00%02/23/2022Get Alert
ALLOAllogene Therapeutics-$0.52-$0.56-$0.57-1.79%$0.00$10.00K$49.00K390.00%11/04/2021Get Alert
ALLOAllogene Therapeutics-$0.53-$0.55-$0.533.64%$0.00$44.00K08/04/2021Get Alert
ALLOAllogene Therapeutics-$0.50-$0.46-$0.2545.65%$0.00$13.92M$38.34M175.47%05/05/2021Get Alert
ALLOAllogene Therapeutics-$0.58-$0.56-$0.535.36%$0.00$3.17M$0.00-100.00%02/25/2021Get Alert
ALLOAllogene Therapeutics-$0.50-$0.54-$0.523.70%$0.00$0.0011/04/2020Get Alert
ALLOAllogene Therapeutics-$0.41-$0.54-$0.531.85%$0.00$0.0008/05/2020Get Alert
ALLOAllogene Therapeutics-$0.32-$0.58-$0.5013.79%$0.00$0.0005/06/2020Get Alert

Allogene Therapeutics (ALLO) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42025-03-13$-0.28$-0.3417.6 %
Q32024-11-07$-0.32$-0.333.03 %
Q22024-08-07$-0.35$-0.350.00 %
Q12024-05-13$-0.38$-0.417.32 %

Allogene Therapeutics (ALLO) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q42025-03-13$0$14.00K-100.0 %
Q32024-11-07$0$10.00K-100.0 %
Q22024-08-07$0$20.00K-100.0 %
Q12024-05-13$22.00K$10.00K120.0 %

FAQ

Q

When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?

A

Allogene Therapeutics (ALLO) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.

Q

What were the latest earnings per share (EPS) for Allogene Therapeutics (NASDAQ:ALLO)?

A

The Actual EPS was $-0.28, which beat the estimate of $-0.34.

Q

What were Allogene Therapeutics’s (NASDAQ:ALLO) revenues?

A

The Actual Revenue was $0K, which missed the estimate of $14K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch